Volume 27, Number 10—October 2021
Synopsis
Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection
Table 3
Outcome | Unexposed, n = 10,532 | Exposed, n = 393 | p value | ASD |
---|---|---|---|---|
Primary outcome† | ||||
Composite adverse obstetric outcome |
19.25 |
22.75 |
<0.001 |
8.62 |
Secondary outcome‡ | ||||
Preeclampsia, eclampsia, or HELLP syndrome | 1.89 | 2.44 | 0.004 | 3.78 |
Pregnancy loss at <24 weeks | 1.06 | 0.71 | 0.034 | 3.73 |
Pregnancy loss at >24 weeks | 1.54 | 1.19 | 0.060 | 2.97 |
Delivery at <32 weeks | 3.18 | 3.63 | 0.052 | 2.51 |
Delivery at <37 weeks | 8.90 | 12.22 | <0.001 | 10.71 |
Spontaneous delivery at <37 weeks | 5.65 | 4.96 | 0.056 | 2.86 |
Caesarean delivery | 24.68 | 26.63 | 0.002 | 4.17 |
Unscheduled caesarean delivery | 12.27 | 13.87 | <0.001 | 4.73 |
Postpartum hemorrhage | 9.23 | 12.57 | <0.001 | 10.74 |
DVT or PE | 0.06 | 0.53 | <0.001 | 8.77 |
*Values are % pregnant women except as indicated. ASD, absolute standardized difference; DVT, deep vein thrombosis; HELLP, hemolysis, elevated liver enzymes, low platelet count; PE, pulmonary embolism. †Significant statistical difference: p < 0.05. ‡Significant statistical difference: p < 0.005 (Bonferroni correction).
Page created: August 02, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.